Moderna's shares plunged on Thursday after data of its breakthrough cancer vaccine developed with Merck got leaked online.
The stock fell up to 25% in the afternoon even though the information was positive compared to what was expected by analysts.
Moderna's shares plunged on Thursday after data of its breakthrough cancer vaccine developed with Merck got leaked online.
The stock fell up to 25% in the afternoon even though the information was positive compared to what was expected by analysts.